Nick Dragojlovic
Overview
Explore the profile of Nick Dragojlovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Regier D, Loewen R, Chan B, Ehman M, Pollard S, Friedman J, et al.
Genet Med
. 2024 Jan;
26(4):101069.
PMID: 38205742
Purpose: To determine real-world diagnostic rates, cost trajectories, and cost-effectiveness of exome sequencing (ES) and genome sequencing (GS) for children with developmental and/or seizure disorders in British Columbia, Canada. Methods:...
2.
Dragojlovic N, Borle K, Kopac N, Nisselle A, Nuk J, Jevon M, et al.
Curr Oncol
. 2023 Aug;
30(8):7241-7251.
PMID: 37623006
Over the last decade, utilization of clinical genetics services has grown rapidly, putting increasing pressure on the workforce available to deliver genetic healthcare. To highlight the policy challenges facing Canadian...
3.
Borle K, Kopac N, Dragojlovic N, Llorian E, Lynd L
Clin Ther
. 2023 Jul;
45(8):695-701.
PMID: 37516568
Rapid growth in the volume of referrals to clinical genetics services in many countries during the past 15 years makes workforce planning a critical policy tool in ensuring that the...
4.
Llorian E, Waliji L, Dragojlovic N, Michaux K, Nagase F, Lynd L
Value Health
. 2023 Mar;
26(8):1258-1269.
PMID: 36990207
Objectives: Early health technology assessment (eHTA) can be used to evaluate and optimize a medical product's value proposition and to inform go/no-go decisions by using health economic modeling, literature scanning,...
5.
Llorian E, Kopac N, Waliji L, Borle K, Dragojlovic N, Elliott A, et al.
Value Health
. 2023 Mar;
26(9):1286-1295.
PMID: 36921900
Objectives: Increasing access to health data through biobanks containing genetic information has the potential to expand the knowledge base and thereby improve screening, diagnosis, and treatment options for many diseases....
6.
Llorian E, Dragojlovic N, Campbell T, Friedman J, Osiovich H, Elliott A, et al.
Genet Med
. 2022 May;
24(8):1675-1683.
PMID: 35622065
Purpose: This study aimed to compare downstream utilization of medical services among critically ill infants admitted to intensive care units who received rapid exome sequencing (ES) and those who followed...
7.
Borle K, Kopac N, Dragojlovic N, Llorian E, Friedman J, Elliott A, et al.
Eur J Hum Genet
. 2022 Jan;
30(5):496-504.
PMID: 35031678
Driven by technological and scientific advances, the landscape of genetic medicine is rapidly changing, which complicates strategic planning and decision-making in this area. To address this uncertainty, we sought to...
8.
Enns E, Wainstein T, Dragojlovic N, Kopac N, Lynd L, Elliott A
Mol Genet Genomic Med
. 2021 Sep;
9(10):e1784.
PMID: 34532994
Background: In Canada, funding for genome-wide sequencing (GWS; exome and whole genome) is provincially regulated. We characterized the uptake of GWS by genetics health professionals (GHPs) across Canada and describe...
9.
Ho J, Borle K, Dragojlovic N, Dhillon M, Kitchin V, Kopac N, et al.
Pharmacoeconomics
. 2021 Jun;
39(9):995-1019.
PMID: 34156648
Objective: The aim of this review was to summarize all available evidence on the cost effectiveness of potentially curative gene therapies and identify challenges that economic evaluations face in this...
10.
Pollard S, Weymann D, Dunne J, Mayanloo F, Buckell J, Buchanan J, et al.
Eur J Hum Genet
. 2021 Jun;
29(10):1589.
PMID: 34145384
No abstract available.